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Abstract sds22 was originally identified in yeast as a regulator 
of protein phosphatase-1 that is essential for the completion of 
mitosis. We show here that a structurally related mammalian 
polypeptide (41.6 kDa) is part of a 260-kDa species of protein 
phosphatase-1. This holoenzyme, designated PP-lN s d s 22, could 
be immunoprecipitated with sds22 antibodies and was retained by 
microcystin-Sepharose. PP-lN s d s 22 is a latent phosphatase, but 
its activity could be revealed by the proteolytic destruction of the 
noncatalytic subunit(s). PP-lN s d s 22 accounted for only 5-10% of 
the total activity of PP-1 in rat liver nuclear extracts. A synthetic 
22-mer peptide, corresponding to a leucine-rich repeat of sds22, 
specifically inhibited the catalytic subunit of PP-1, showing that 
at least part of the latency stems from the interaction of the 
sds22 repeat(s) with P P - l o 
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1. Introduction 
The Ser/Thr protein phosphatases of type 1 (PP-1) comprise 
a conserved and widely distributed family of enzymes with 
functions in various cellular processes (reviewed in [1,2]). 
They all contain the same catalytic subunit (PP- lc) , which 
is structurally related to that of other protein phosphatases 
like PP-2A and PP-2B, but can easily be distinguished from 
the latter enzymes by its substrate specificity and sensitivity to 
inhibitory polypeptides and toxins. All known PP-1 holoen-
zymes contain one or two regulatory subunits that control the 
activity and substrate specificity of the phosphatase, and tar-
get the holoenzyme to its physiological substrate(s). The best 
characterized cytoplasmic targeting subunits of PP-1 are the 
G- and M-subunits that anchor the phosphatase to the glyco-
gen particles and to myofibrils, respectively. 
The nucleus of mammalian cells contains two major holo-
enzymes of PP-1 , designated P P - l N R 4 i and P P - l N R m [3]. 
They are both heterodimers of the catalytic subunit and in-
hibitory polypeptides of 41 and 111 kDa, respectively. R41 
was identified as NIPP-1 , a phosphopolypeptide with struc-
tural features like that of some proteins implicated in R N A 
processing [4]. Other nuclear polypeptides that have been 
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shown to interact with the catalytic subunit include the reti-
noblastoma protein [5], the p53-binding protein p53BP2 [6] 
and the splicing factor PSF [7], but it is not clear yet whether 
these polypeptides represent real subunits of PP-1 . In addi-
tion, we have cloned a mammalian protein of 42 k D a that is 
enriched in the nucleus and is structurally related (46% iden-
tity) to the yeast protein sds22 [8]. The similarity includes a 
tandem array of 11 leucine-rich repeat structures of 22 resi-
dues. sds22 has been genetically identified as a positive regu-
lator of PP-1 in yeast [9]. Both immunoprecipitation and two-
hybrid analysis have shown that sds22 is physically associated 
with P P - l c in yeast [10-12]. 
There is no information on the physiological role of sds22 
in higher eukaryotes or on its potential interaction with PP-1 . 
We show here that sds22 is an inhibitory subunit of a rare 
nuclear species of PP-1 in rat liver and provide initial evidence 
that this inhibition is, at least partially, mediated by interac-
tion of the catalytic subunit with the repeat structure of sds22. 
2. Materials and methods 
2.1. Materials 
PP-lc [13], PP-2AC [14], inhibitor-2 [15], and phosphorylase b [16] 
were purified from rabbit skeletal muscle. Protein kinase p34''d<'2 was 
purified from Xenopus oocytes by affinity chromatography on pi 3-
Sepharose [17]. Microcystin-LR, histone IIA, myelin basic protein 
and the catalytic subunit of the cAMP-dependent protein kinase 
from beef heart were purchased from Sigma. Histone HI and the 
digoxigenin protein labeling and detection kit were obtained from 
Boehringer. Protein A coupled to TSK beads was obtained from Affi-
land (Liege, Belgium). Affi-T-agarose, used for the purification of 
immunoglobulins, was purchased from KemEnTtec (Denmark). Poros 
20 HQ was delivered by PerSeptive Biosystems (Framingham, MA, 
USA). A kit for the development of Western blots by enhanced 
chemiluminescence was purchased from Amersham Corp. Amino-
ethanethiol-microcystin (0.5 mg) was prepared and coupled to acti-
vated CH-Sepharose 4B (3 ml) according to the procedure of Moor-
head et al. [18]. Synthetic peptides were synthesized with a Milligen 
9050, using the Ar-(9-fluorenyl)methoxycarbonyl mode. 
Phosphorylase b was phosphorylated in the presence of [32P]ATP by 
purified phosphorylase kinase [19]. Myelin basic protein and histone 
IIA were phosphorylated by the catalytic subunit of cAMP-dependent 
protein kinase [20], and histone HI was phosphorylated by p34cdc2 
[17]. 
2.2. Preparation of nuclear extracts and partial purification of 
PP-lNsdi,22 
Intact rat liver nuclei were prepared as described by Jagiello et al. 
[3]. The nuclei were first washed by resuspension with a Dounce ho-
mogenizer (A pestle) in a buffer containing 20 mM Tris-HCl at pH 
7.4, 1 mM MgCl2 and 0.25 M sucrose, and subsequent resedimenta-
tion by centrifugation for 3 min at 3500 Xg. The nuclear pellet was 
resuspended with the B pestle in buffer A (consisting of 50 mM gly-
cylglycine/NaOH at pH 7.4, 5 mM 2-mercaptoethanol and 0.5 mM 
dithiothreitol) plus 0. 3 M NaCl and 0.5% (v/v) Triton X-100. After 
an incubation for 30 min at 4°C on a rotating wheel, the nuclear 
particulate fraction was sedimented by centrifugation (10 min at 
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13000Xg). The supernatant is further referred to as the 'nuclear ex-
tract'. 
The nuclear extract prepared from the liver of 15 rats was dialyzed 
against buffer A plus 50 mM NaCl, and applied to a Poros 20 HQ 
column (1.7 ml), equilibrated in the same buffer. Bound proteins were 
eluted with 34 ml of a linear salt gradient (50-1000 mM NaCl in 
buffer A). The fractions were assayed for trypsin-revealed phospho-
rylase phosphatase activities. In agreement with previous data [3], this 
assay revealed two phosphatase activity peaks. The fractions of the 
first eluted phosphatase, which contain mainly PP-1NR4I (see Section 
3), were pooled, concentrated on a Biomax-10 ultrafiltration mem-
brane (Millipore) until 200 ul, and applied to a Superdex-200 gel 
filtration column (24 ml), equilibrated with buffer A plus 150 mM 
NaCl. Fractions of 0.25 ml were collected and assayed for spontane-
ous and trypsin-revealed phosphorylase phosphatase activities and 
immunodetectable sds22 (Fig. 1). 
2.3. Immunological techniques and assays 
Antibodies against a synthetic peptide encompassing the 11 carbox-
yl-terminal residues of NIPP-1 from bovine thymus were raised in a 
rabbit and purified by chromatography on Affi-T-agarose [3]. A syn-
thetic peptide with a sequence corresponding to the 14 C-terminal 
residues of human sds22 [8], plus an additional N-terminal cysteine, 
was coupled to keyhole limpet hemocyanin using the Pierce immuno-
gen conjugation kit. Rabbit polyclonal antibodies to the hemocyanin-
coupled peptide were purified by chromatography on Affi-T-agarose. 
The NIPP-1 and sds22 antigenic peptides do not show any similarity 
and their antibodies did not cross-react. For Western analysis the 
antibodies were used at a final dilution of 10 (ig/ml, and the perox-
idase-labeled secondary antibodies were detected by enhanced chem-
iluminescence. For immunoprecipitation, 100 ul PP-lNs(jS22, purified 
until after Superdex-200 (Fig. 1), was incubated for 2h at 4°C with 
10 (j.1 anti-sds22 IgG fraction (10 mg/ml) in the presence of 0.3 mM 
phenylmethanesulfonyl fluoride, 50 uM l-chloro-3-tosylamido-7-ami-
no-2-heptanone (TLCK), 50 U.M L-l-tosylamido-2-phenylethyl chlor-
omethyl ketone (TPCK) and 5 |J.M leupeptin. Subsequently, 30 ul of 
protein-A TSK was added, and the mixture was incubated during 
30 min at 4°C on a rotating wheel. Following centrifugation (5 min 
at lOOOOXg), the pellet was washed twice with 0.2 ml of buffer A plus 
50 mM NaCl, and resuspended in the same medium to a final volume 
of 50 (j.1. 
Far-Western blotting with digoxigenin-bound PP-lc was performed 
according to Jagiello et al. [3], The spontaneous and trypsin-revealed 
('total') protein phosphatase activities were measured as described 
previously [20]. 
3. Results and discussion 
3.1. Identification of PP-1N¡¡¿S22 
Fractionation of a hepatic nuclear extract on M o n o Q [3] or 
Poros H Q (not shown) revealed the presence of two major 
peaks of phosphorylase phosphatase activity eluting at about 
0.2 M and 0.3 M NaCl, which correspond to the previously 
characterized P P - 1 N R 4 1 and P P - l N r m i , respectively [3]. 
Screening of the Poros H Q fractions by Western analysis 
with antibodies against the C-terminus of sds22 showed that 
this protein co-eluted with P P - 1 N R 4 I (not illustrated). How-
ever, subsequent gel filtration on Superdex-200 resulted in a 
nearly complete separation between PP-lN R 4i and a small 
peak of phosphorylase phosphatase activity, termed PP-
lNs(jS22 (Fig. 1A). The latter phosphatase migrated like a pro-
tein of 260 k D a and co-eluted with immunodetectable sds22 
(Fig. IB). In contrast, NIPP-1 co-migrated with P P - 1 N R 4 I , as 
indicated by Western analysis with NIPP-1 antibodies (not 
shown) and by far-Western blotting with digoxigenin-labeled 
P P l c (Fig. 1C). The phosphorylase phosphatase activity of 
PP-lNsds22 could only be detected after prior proteolysis 
with trypsin. This phosphatase activity stemmed from PP-1 , 
as indicated by its complete inhibition with 0.1 u M inhibitor-2 
(not shown), a specific inhibitor of PP-1 [1]. Since the phos-
phatase activity of the free catalytic subunit of PP-1 is hardly 
affected by trypsin under the adopted conditions (Table 1 and 
[3]), the latency of PP-lNs(jS22 must be explained by associa-
tion of the catalytic subunit with one or more trypsin-sensitive 
inhibitory polypeptides. Using phosphorylase as a substrate, 
Fig. 1. Separation of PP-lNS(jS22 and PP-1NR4I by gel filtration. As described in Section 2, the 0.2 M NaCl pool from the Poros HQ column, 
containing mainly PP-lNR4i, was applied to a Superdex-200 column. The fractions were assayed for spontaneous (o) and trypsin-revealed (•) 
phosphorylase phosphatase activities (A), for immunodetectable sds22 (panel B) and for NIPP-1 by far-Western blotting with digoxygenin-la-
beled PPlc (C). For the immunodetection of sds22, the samples were first concentrated 10-fold by lyophihzation. The arrows indicate the elu-
tion position of marker proteins, i.e. ferritin (440 kDa), catalase (232 kDa), aldolase (158 kDa) and bovine serum albumin (67 kDa). 
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Fig. 2. PP-lNs<js22 is retained by microcystin-Sepharose. A nuclear 
extract from the livers of 15 rats was applied to a microcystin-Se-
pharose column (3 ml), equilibrated in buffer A containing in addi-
tion 0.25 M NaCl. After washing of the column with 10 volumes of 
the same buffer, the retained proteins were eluted with 10 volumes 
of buffer A containing 3 M KSCN. The eluate was concentrated to 
200 ul on a Biomax-10 ultrafiltration membrane (Millipore) and an-
alyzed by far-Western blotting with digoxigenin-labeled PP-lc (left 
lane) and by Western blotting with sds22 antibodies (right lane). 
the total (i.e. trypsin-revealed) activity of PP-lNsds22 was esti-
mated to account for 5-10% of the total activity of PP-1 in a 
rat liver nuclear extract (not shown). 
Direct evidence for an association between sds22 and PP-lc 
came from chromatography of a nuclear extract on microcys-
tin-Sepharose, which specifically and covalently binds PP-lc 
[18]. We found that sds22 was retained by this affinity matrix, 
as detected by Western analysis of the 3 M KSCN eluate (Fig. 
2). Interestingly, microcystin-Sepharose also bound other nu-
clear species of PP-1, as indicated by the large fraction of 
phosphorylase phosphatase activity that was retained (ca. 
80% of the total applied activity) and by far-Western blotting 
with digoxigenin-labeled catalytic subunit. Among the pro-
teins that were visualized by an overlay with catalytic subunit 
were polypeptides of 41 and 111 kDa, corresponding to 
NIPP-1 and R i l l , respectively. Remarkably, far-Western 
blotting did not visualize sds22 (see also Fig. 1C), which mi-
Table 1 
Effect of trypsin on the protein phosphatase activities of PP-lc 
PP-lNsds22 
and 
Substrate 
Phosphorylase a 
Histone HI 
Histone IIA 
Myelin basic protein 
Protein phosphatase activity after trypsin 
(% of spontaneous activity) 
PP-lc 
116±17 
127 ±13 
110± 12 
125 ±3 
PP-lNsds22 
1869 ±343 
257 ± 32 
1281 ±263 
1320 ±227 
PP-lNsds22, purified until after Superdex-200, was immunoprecipitated 
with sds22 antibodies, as described in Section 2. The washed immu-
noprecipitate and purified PP-lc were assayed from spontaneous and 
trypsin-revealed protein phosphatase activities. The results are ex-
pressed as a percentage of the spontaneous activity and represent 
the means ± S.E.M. for 3-6 assays. 
grated as a slightly larger polypeptide than NIPP-1 during 
glycine SDS-PAGE (Fig. 2). This suggests that sds22, like 
inhibitor-2 [3], does not retain its PP-1 binding properties 
after denaturing electrophoresis. In view of the low abundance 
of PP-lNSds22 it cannot be ruled out, however, that the con-
centration of sds22 was limiting for detection by far-Western 
blotting. 
Additional evidence that sds22 is a part of PP-lNSdS22 came 
from observations that a fraction of the holoenzyme (38 ± 4%; 
n = 3) could be immunoprecipitated with sds22 antibodies. 
The immunoprecipitated phosphatase was latent, but the ac-
tivity was increased 2-18-fold by prior proteolysis, depending 
on the substrate used (Table 1). In contrast, the free catalytic 
subunit (Table 1) and the fraction of PP-lNsaS22 that was not 
immunoprecipitated (not illustrated) showed only a small ac-
tivity increase after trypsin treatment. Since the sample before 
immunoprecipitation was completely latent (see Fig. 1), this 
suggests that the non-immunoprecipitable PP-lNsds22 repre-
sents a fraction that was proteolyzed or dissociated during 
immunoprecipitation. A similar sensitivity to proteolysis dur-
ing immunoprecipitation has also been noted before for R i l l 
[3]. 
3.2. Inhibition of PP-lc by a synthetic leucine-rich repeat unit 
of sds22 
Leucine-rich repeats are short sequence motifs of variable 
length present in various polypeptides with diverse functions 
and cellular locations [21]. They consist of a short ß-strand 
and an a-helix arranged approximately parallel to one anoth-
er. All proteins containing these repeats are thought to be 
involved in protein-protein interactions. Stone et al. [10] 
have previously shown that the interaction of sds22 with 
PP-lc in fission yeast is dependent upon the presence of 
some leucine-rich repeats. We have found that a synthetic 
peptide (ENLSNLHQLQMLELGSNRIRAI) with a primary 
structure corresponding to that of the sixth repeat (residues 
100 
80 -
o 
Ü 60 
40 
t 20 -
P180-201 (fJM) 
Fig. 3. Effects of a synthetic leucine-rich repeat of sds22 on the ac-
tivities of PP-lc and PP-2Ac. The phosphorylase phosphatase activ-
ity of the catalytic subunits of PP-1 and PP-2A was assayed in the 
presence of the indicated concentrations of a synthetic peptide 
(pl80-201) encompassing residues 180-201 of human sds22. Results 
are expressed as a percentage ± S.E.M. of the control activity (n = 4). 
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180-201) of human sds22 was inhibitory to the phosphorylase 
phosphatase activity of PPlc (Fig. 3). Half-complete inhibi-
tion was obtained at 25 u.M. Interestingly, the same concen-
trations of pi80-201 did not affect PP-2Ac, providing addi-
tional evidence that the interaction of sds22 with the type-1 
catalytic subunit is specific and mediated by the repeat struc-
ture. Although these results suggest that sds22 inhibits PP-lc, 
we have up to now not been able to obtain sufficient native or 
recombinant sds22 for functional studies. 
the glycogen-binding G-subunit is inhibitory to the phospho-
rylase phosphatase activity of the catalytic subunit, but is 
required to recognize glycogen synthase as a substrate. 
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3.3. Conclusions 
We show here that sds22 is a subunit of a latent high-mo-
lecular-weight species of PP-1. The main evidence is that sds22 
copurifies with PP-1 during anion exchange chromatography 
(not illustrated), during gel filtration (Fig. 1) and during af-
finity chromatography on microcystin-Sepharose (Fig. 2). In 
addition, we have shown that PP-1 co-immunoprecipitates 
with sds22 (Table 1). In retrospect, it is easy to understand 
why PP-lNsdS22 escaped our previous attention, since its ac-
tivity accounts only for 5-10% of the total nuclear activity of 
PP-1 and can only be revealed after trypsinolysis. Since hep-
atocytes are nearly all in the G0 phase of the cell cycle, our 
data show that sds22 is phosphatase-associated in resting 
cells. It cannot be excluded, however, that this association is 
cell cycle regulated. 
The estimated mass of PP-lNsds22 (260 kDa) is much higher 
than expected from the combined masses of PP-lc and sds22 
(ca. 80 kDa). Although we cannot rule out that the holoen-
zyme is a polymer of these subunits, it seems more likely that 
PP-lNsdS22 contains additional regulatory subunit(s). This is in 
agreement with a preliminary biochemical analysis in fission 
yeast, where sds22 was found to be associated with both PPlc 
and a phosphoprotein of 25 kDa [10]. Obvious candidates as 
additional regulatory subunits of PP-lNS(jS22 are p53BP2, the 
retinoblastoma protein and PSF, which have previously al-
ready been identified as nuclear regulators of PP-1 (see Sec-
tion 1). 
sds22 has been genetically identified as a positive regulator 
of PP-1 in yeast [9]. Our finding that PP-lNsds22 is a latent 
enzyme and that this latency is, at least partially, mediated by 
the leucine-rich repeat motif of sds22 is somewhat surprising, 
but not necessarily at variance with its proposed role as a 
'positive' effector of PP-1. Indeed, it is quite possible that 
the effect of sds22 is substrate-dependent, as indicated by 
the lower degree of latency of the holoenzyme with histone 
HI as substrate (Table 1). This is in keeping with the known 
effects of other regulatory subunits of PP-1 [1,2]. For example, 
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